BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Restore Vision Reports Encouraging Phase I II Data For RV 001 Gene Therapy In Retinitis Pigmentosa

Phase I/II clinical trial interim results, out to 168 days, from the two RV-001 dosing cohorts with advanced Retinitis Pigmentosa are presented at key Ma...

May 02, 2026 | News

Lakewood Amedex Advances Nu 3 Bisphosphocin Candidate With Strong AMR Resistance Profile

Nu-3 represents a novel class of potent, fast-acting, broad-spectrum antimicrobials called Bisphosphocins® Lakewood-Amedex Biotherapeutics Inc., (NASD...

May 02, 2026 | News

ACROBiosystems And SeromYx Partner To Advance Functional Profiling Of Anti CD20 Antibodies

ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collabora...

May 01, 2026 | News

Formosa Pharmaceuticals And SERI Partner To Advance Next Generation Ophthalmic Therapies

The collaboration aims to address significant unmet needs in the treatment of corneal and ocular surface diseases. By combining innovative ...

May 01, 2026 | News

HistoIndex Expands US Clinical Network With New Hepatology And Gastroenterology Partnerships

HistoIndex, a pioneer in AI-driven digital pathology solutions for chronic liver disease, has announced the continued expansion of its commercial partnersh...

April 30, 2026 | News

C-Ray Therapeutics Activates FDA DMF For Copper 64 Radiolabelling To Enable Global IND And NDA Submissions

DMF No. 43568 is now active and available for reference in global IND and NDA submissions C-Ray Therapeutics (Chengdu) Co., Ltd., announced that its Type ...

April 30, 2026 | News

IMG Pharmaceutical Co Ltd To Acquire Matsumoto Pharmaceutical Co Ltd To Strengthen Integrated Healthcare Platform

IMG Pharmaceutical Co., Ltd. ("IMG Pharma"), a majority-owned subsidiary of IMG Japan, the Group's holding company, announced that it has entered into a de...

April 29, 2026 | News

Cellenkos Inc. Receives U.S. Food and Drug Administration Clearance To Advance CK0801 Phase 2 Trial In Aplastic Anemia

Phase 2 multicenter, open-label study (NCT07499102) will evaluate the safety and clinical efficacy of CK0801 Tregs in transfusion-dependent aplastic anemia...

April 29, 2026 | News

Xcovery Partners With EVERSANA To Expand U.S. Launch Of ENSACOVE For ALK Positive Lung Cancer

Xcovery Holdings, Inc., (Xcovery) an evidence-based, innovation-driven pharmaceutical company, announced an agreement with EVERSANA®, a leading p...

April 29, 2026 | News

Berlin Heals Reports Positive First In Human Results For Less Invasive CMIC Therapy In Heart Failure

High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Lef...

April 27, 2026 | News

Ascletis Completes Enrollment For Phase II Study Of Oral GLP 1R Agonist ASC30 In Type 2 Diabetes

- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-d...

April 27, 2026 | News

AscendCare Launches Public Initiative To Normalise Preventive Health Screenings

AscendCare Medical Clinic, a modern healthcare provider based in Tanjong Pagar, today announced a new public education initiative designed to reframe healt...

April 24, 2026 | News

Prestige Biopharma IDC Files Patent For Next Generation Subcutaneous Antibody Delivery Platform

Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation ...

April 24, 2026 | News

Everest Medicines Reports Promising First In Human Data For Personalised mRNA Cancer Vaccine EVM16

Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...

April 24, 2026 | News

Stay Connected